Abbott | ABT - Vermögenswerte

Aktienkurs
90.67
Täglich Wechseln
-0.66 -0.72%
Monatlich
-11.69%
Jährlich
-30.72%
Q2 Prognose
89.18




Vermögenswerte Veränderung Datum
Abbott USD 110.43B 23.72B 2026-03
Agilent USD 12.81B 86M 2025-12
AtriCure USD 654.18M 18.74M 2025-12
Baxter International USD 20.06B 1.01B 2025-12
Becton, Dickinson and Co. USD 54.84B 484M 2025-12
Bio-Rad Laboratories USD 10.58B 880.1M 2025-12
Boston Scientific USD 43.67B 966M 2025-12
Cooper Companies USD 12.42B 29.4M 2025-12
Danaher USD 83.54B 80M 2026-03
Dexcom USD 6.34B 1.16B 2025-12
Edwards Lifesciences USD 13.7B 425M 2025-12
Globus Medical USD 5.3B 207.12M 2025-12
Insulet USD 3.19B 161.1M 2025-12
Integra LifeSciences USD 3.6B 44.45M 2025-12
Intuitive Surgical USD 20.11B 347.7M 2026-03
J&J USD 200.89B 1.68B 2026-03
Masimo USD 1.7B 118.6M 2025-12
Medtronic USD 91.48B 139M 2025-12
Merit Medical Systems USD 2.69B 54.92M 2025-12
Pfizer USD 208.73B 2.64B 2025-09
Smith & Nephew USD 10.69B 150M 2025-12
Solventum Corp USD 14.29B 321M 2025-12
Stryker USD 47.84B 787M 2025-12
Tandem Diabetes Care USD 881.11M 6.46M 2025-12
Teleflex USD 6.95B 924.7M 2025-12
Terumo JPY 2.26T 362.12B 2025-12
Thermo Fisher Scientific USD 113.28B 2.94B 2026-03
Zimmer Biomet Holdings USD 22.72B 370.1M 2026-03